View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

Scientists find benefits of Tamiflu overestimated

A new study raises concerns that the effect of the vastly popular influenza treatment drug may have been overestimated.
Read More

US demand for pharma excipients to rise 4.3% per year through 2018

Excipients in oral formulations, such as tablets and capsules, will be well positioned for strong market performance.
Read More

Horizon Pharma buys Irish drug maker Vidara

Illinois-based Horizon Pharma Inc. announced last week it was taking over Irish Vidara Therapeutics International Ltd. in a reverse merger, moving its headquarters to Dublin.
Read More

FDA bans import of drugs from Sun Pharma's Gujarat facility

The U.S. FDA has issued an import alert for Indian drug maker Sun Pharmaceuticals Ltd., banning the import of drug products manufactured at the company's facility in Gujarat.
Read More

EU to destroy transit counterfeit drugs

The European Union has approved a revision of its trademark legislation, including a provision that allows EU customs to block and destroy counterfeit branded pharmaceutical products, even if they are intended for markets outside the union.
Read More

Endo Pharmaceuticals settles lawsuit over unlawful marketing

Pharmaceutical companies Endo Pharmaceuticals and Endo Health Solutions will have to pay $192.7 million to resolve criminal and civil charges related to their marketing policy for the product Lidoderm.
Read More

US, Indian officials meet to discuss drug safety

India and the United States have been locked in a regulatory conflict over generic pharmaceutical products distributed on the U.S. market.
Read More

Mexico's Neolpharma opens R&D facility in Puerto Rico

The Center for the Development and Innovation of Pharmaceutical Products, or Cediprof, will focus on research and experimentation of generic drugs.
Read More

Another Ranbaxy facility lands on FDA blacklist

The U.S. Food and Drug Administration (FDA) has added Ranbaxy's Toansa plant to the list of Indian facilities included on the consent decree dated January 2012.
Read More

Israel's Teva to buy NuPathe for $144 million

Pennsylvania-based NuPathe specializes in therapeutics for diseases of the central nervous system (CNS), including neurological and psychiatric disorders.
Read More